These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2641003)
41. Issues in the analysis of clinical trials for opiate dependence. Follmann D; Wu M; Geller N NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019 [No Abstract] [Full Text] [Related]
42. A Markov model for NIDA data on treatment of opiate dependence. Lee ML NIDA Res Monogr; 1992; 128():160-7; discussion 168-9. PubMed ID: 1436013 [No Abstract] [Full Text] [Related]
43. Toward a dynamic analysis of disease-state transition monitored by serial clinical laboratory tests. Weng TS NIDA Res Monogr; 1992; 128():137-57; discussion 158-9. PubMed ID: 1436011 [No Abstract] [Full Text] [Related]
44. Marijuana use by methadone maintenance patients. Saxon AJ; Calsyn DA; Blaes PA; Haver VM; Greenberg DM NIDA Res Monogr; 1990; 105():306-7. PubMed ID: 1876021 [No Abstract] [Full Text] [Related]
45. Methadone maintenance outcome as a function of detoxification fear: preliminary findings. Milby JB; Gentile M; Sims MK; McLellan AT; Woody G; Haas N NIDA Res Monogr; 1990; 105():589-90. PubMed ID: 1876132 [No Abstract] [Full Text] [Related]
46. Opioid substitution and HIV/AIDS treatment and prevention. Kerr T; Wodak A; Elliott R; Montaner JS; Wood E Lancet; 2004 Nov 27-Dec 3; 364(9449):1918-9. PubMed ID: 15566992 [No Abstract] [Full Text] [Related]
47. Is there a better way to match patients to opioid maintenance treatment: a case report. Fareed A; Casarella J; Amar R; Drexler K Am J Addict; 2009; 18(2):180-1. PubMed ID: 19283573 [No Abstract] [Full Text] [Related]
48. Electroencephalographic and behavioral correlates of buprenorphine administration. Lukas SE; Jasinski DR; Johnson RE Clin Pharmacol Ther; 1984 Jul; 36(1):127-32. PubMed ID: 6734042 [TBL] [Abstract][Full Text] [Related]
49. Depressive symptoms during buprenorphine treatment of opioid abusers. Kosten TR; Morgan C; Kosten TA J Subst Abuse Treat; 1990; 7(1):51-4. PubMed ID: 2313769 [TBL] [Abstract][Full Text] [Related]
50. Medical methadone/interim report. Senay E; Barthwell AG; Marks R; White R NIDA Res Monogr; 1990; 105():582-3. PubMed ID: 1876129 [No Abstract] [Full Text] [Related]
51. Comments on Mattick et al.: the need for independent data re-analyses. Caplehorn J Addiction; 2003 Nov; 98(11):1633-4. PubMed ID: 14616190 [No Abstract] [Full Text] [Related]
52. Reduction of the frequency of drug use of veterans Enrolled in an outpatient methadone maintenance treatment program. Eisenberg M; Isaacs CD; Bourque A Int J Addict; 1981 Oct; 16(7):1277-80. PubMed ID: 7327791 [No Abstract] [Full Text] [Related]
53. [Methadone treatment--for whom?]. Furuholmen D Tidsskr Nor Laegeforen; 1992 May; 112(14):1864-5. PubMed ID: 1631853 [No Abstract] [Full Text] [Related]
54. Evaluation of a methadone rehabilitation program. Graham-Bafus S; Allen RH; Gordon JR Psychol Rep; 1984 Aug; 55(1):99-106. PubMed ID: 6484100 [No Abstract] [Full Text] [Related]
55. From maintenance to abstinence in a therapeutic community: preliminary results. Sorensen JL; Acampora AP; Deitch DA J Psychoactive Drugs; 1984; 16(1):73-7. PubMed ID: 6726506 [No Abstract] [Full Text] [Related]
56. Locus of control and initiation of detoxification among male methadone maintenance patients. Langrod J; Des Jarlais DC; Alksne L; Lowinson J Int J Addict; 1983 Aug; 18(6):783-90. PubMed ID: 6629579 [TBL] [Abstract][Full Text] [Related]